Ji-Hyoun Kang Selected Research

Ji-Hyoun Kang Research Topics

Disease

6	Pain (Aches) 07/2023 - 12/2017
5	Rheumatoid Arthritis 12/2023 - 09/2014
5	Lupus Nephritis 12/2023 - 02/2018
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2023 - 05/2017
5	Fibromyalgia (Fibrositis) 01/2022 - 05/2017
4	Sclerosis 01/2023 - 02/2018
3	Ankylosing Spondylitis 01/2023 - 09/2014
3	Osteoarthritis 01/2023 - 04/2018
3	Chronic Renal Insufficiency 09/2021 - 02/2015
2	Inflammation (Inflammations) 12/2023 - 01/2023
2	Osteophyte 01/2023 - 01/2021
2	Chronic Pain 01/2020 - 05/2017
1	Tenosynovitis 07/2023
1	Fever (Fevers) 02/2023
1	Myalgia 02/2023
1	Ischemia 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Shock 01/2023
1	Arthritis (Polyarthritis) 01/2023
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2022
1	Adult-Onset Still's Disease 01/2022
1	Hypertension (High Blood Pressure) 12/2021
1	Bone Cysts (Bone Cyst) 01/2021
1	Atrophy 02/2018
1	Fibrosis (Cirrhosis) 02/2018
1	Osteoporosis 01/2016
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 09/2015
1	Gout 02/2015
1	Cicatrix (Scar) 02/2015
1	Ankylosis 01/2015
1	Carpal Tunnel Syndrome 07/2013

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 12/2023 - 09/2015
2	LigandsIBA 12/2023 - 01/2023
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 06/2023 - 02/2018
2	Prednisolone (Predate)FDA LinkGeneric 06/2023 - 12/2021
2	C-Reactive ProteinIBA 02/2023 - 04/2018
2	GlucocorticoidsIBA 01/2023 - 01/2016
2	aminoalcoholphosphotransferase (AAPT)IBA 01/2022 - 06/2021
2	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 09/2014
2	ametantrone (HAQ)IBA 09/2019 - 12/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 07/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 09/2014
1	CholesterolIBA 12/2023
1	oxidized low density lipoproteinIBA 12/2023
1	Histones (Histone)IBA 12/2023
1	LipidsIBA 12/2023
1	HDL CholesterolIBA 12/2023
1	LDL CholesterolIBA 12/2023
1	Nucleosomes (Nucleosome)IBA 12/2023
1	Triglycerides (Triacylglycerol)IBA 12/2023
1	ChemokinesIBA 12/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	CC ChemokinesIBA 12/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	CalciumIBA 01/2023
1	MagnesiumIBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	Phosphates (Orthophosphate)IBA 01/2023
1	curdlanIBA 01/2023
1	InterferonsIBA 01/2023
1	IonsIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 09/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Uric Acid (Urate)IBA 09/2021
1	AdiponectinIBA 01/2021
1	CreatinineIBA 05/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019
1	Anticardiolipin AntibodiesIBA 07/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2017
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	Allopurinol (Remid)FDA LinkGeneric 02/2015
1	Adalimumab (Humira)FDA Link 01/2015

Therapy/Procedure

4	Therapeutics 07/2023 - 01/2015
1	Laparotomy 01/2023
1	Transcranial Direct Current Stimulation 01/2020